Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego researchers describe new use of leukemia drug, nilotinib, to treat subtype of medulloblastoma, a deadly pediatric brain cancer.
The College of Healthcare Information Management Executives (CHIME) has announced that UC San Diego Health has earned 2019 CHIME HealthCare’s Most Wired recognition and is a recipient of their prestigious Quality Award under the Most Wired program.
Two surgical procedures used to repair vaginal prolapse — hysterectomy and employing mesh support that preserves the uterus — have comparable clinical outcomes after three years, according to new data from researchers at University of California San Diego School of Medicine.
New technology from Cydar is allowing UC San Diego Health surgeons to repair aneurysms previously deemed inoperable.
An international team of researchers has discovered a cause for a rare eye disease affecting the macula that leads to loss of central vision, called macular telangiectasia type 2 (MacTel).
UC San Diego researchers say that measuring how quickly a person’s pupil dilates while they are taking cognitive tests may be a low-cost, low-invasive method to aid in screening individuals at increased genetic risk for AD before cognitive decline begins.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
